Education
About Us
Working with TipRanks
Follow Us
Nexalin Technology, Inc. (NXL)
:NXL
NXL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.53 - $4.49
Previous CloseN/A
Volume286.46K
Average Volume (3M)182.25K
Market Cap
$28.74M
Enterprise ValueN/A
Total Cash (Recent Filing)$78.44K
Total Debt (Recent Filing)$689.04K
Price to Earnings (P/E)―
Beta0.87
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.75
Shares Outstanding13,303,523
10 Day Avg. Volume103,066
30 Day Avg. Volume182,255
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)187.66
Price to Cash Flow (P/CF)-7.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$5.00Price Target Upside131.48% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Bulls Say, Bears Say
Bulls Say
Innovation And TechnologyNXL is focused on revolutionizing the treatment of a wide range of mental health conditions using the company's proprietary transcranial alternating current stimulation (tACS) technology.
Market PositionAs the first potential at-home tACS treatment for mental health, NXL could gain a first-mover advantage and set the standard for the market.
Regulatory ApprovalsNXL has received approval from the FDA for pilot trial designs for the treatment of insomnia with its Gen-3 device.
Bears Say
Financial PerformanceNXL reported a GAAP net loss per share wider than the estimate due mostly to higher than expected operating expenses.
Investment RiskAnalysts advise investors not to purchase additional shares at this time as they believe the risk/reward is balanced.
Stock EvaluationThe share price has surpassed the previous price target, leading analysts to downgrade the stock rating from Buy to Hold as they view it as fairly valued.
---
Ownership Overview
18.05% Insiders
1.55% Mutual Funds
0.23% Other Institutional Investors
78.96% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NXL FAQ
What was Nexalin Technology, Inc.’s price range in the past 12 months?
Nexalin Technology, Inc. lowest stock price was $0.53 and its highest was $4.49 in the past 12 months.
What is Nexalin Technology, Inc.’s market cap?
Nexalin Technology, Inc.’s market cap is $28.74M.
When is Nexalin Technology, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nexalin Technology, Inc.’s earnings last quarter?
Currently, no data Available
Is Nexalin Technology, Inc. overvalued?
According to Wall Street analysts Nexalin Technology, Inc.’s price is currently Undervalued.
Does Nexalin Technology, Inc. pay dividends?
Nexalin Technology, Inc. does not currently pay dividends.
What is Nexalin Technology, Inc.’s EPS estimate?
Nexalin Technology, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nexalin Technology, Inc. have?
Nexalin Technology, Inc. has 13,303,523 shares outstanding.
What happened to Nexalin Technology, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nexalin Technology, Inc.?
Currently, no hedge funds are holding shares in NXL
---
Nexalin Technology, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.00 (131.48% Upside)
$5.00 (131.48% Upside)
Blogger Sentiment
Bullish
NXL Sentiment 70%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth $31.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 6.4%
Last 30 Days ▼ 6.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
237.09%
12-Months-Change
Fundamentals
Return on Equity
-221.05%
Trailing 12-Months
Asset Growth
16.27%
Trailing 12-Months
Company Description
Nexalin Technology, Inc.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.
---
NXL Stock 12 Month Forecast
Average Price Target
$5.00
▲(131.48% Upside)
Technical Analysis
Best Analysts Covering NXL
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
+279.35%
upgraded a buy rating 5 days ago
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +279.35% per trade.
---